FI922905L - Framstaellning och anvaendning av imidazolfoereningar - Google Patents

Framstaellning och anvaendning av imidazolfoereningar Download PDF

Info

Publication number
FI922905L
FI922905L FI922905A FI922905A FI922905L FI 922905 L FI922905 L FI 922905L FI 922905 A FI922905 A FI 922905A FI 922905 A FI922905 A FI 922905A FI 922905 L FI922905 L FI 922905L
Authority
FI
Finland
Prior art keywords
imidazolfoereningar
framstaellning och
och anvaendning
anvaendning
framstaellning
Prior art date
Application number
FI922905A
Other languages
English (en)
Finnish (fi)
Other versions
FI922905A0 (fi
FI922905A7 (fi
Inventor
Oskar Axelsson
Mikkel Thaning
Peter Moldt
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of FI922905A0 publication Critical patent/FI922905A0/fi
Publication of FI922905A7 publication Critical patent/FI922905A7/fi
Publication of FI922905L publication Critical patent/FI922905L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Eye Examination Apparatus (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
FI922905A 1991-06-24 1992-06-22 Framstaellning och anvaendning av imidazolfoereningar FI922905L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72002191A 1991-06-24 1991-06-24

Publications (3)

Publication Number Publication Date
FI922905A0 FI922905A0 (fi) 1992-06-22
FI922905A7 FI922905A7 (fi) 1992-12-25
FI922905L true FI922905L (fi) 1992-12-25

Family

ID=24892332

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922905A FI922905L (fi) 1991-06-24 1992-06-22 Framstaellning och anvaendning av imidazolfoereningar

Country Status (14)

Country Link
EP (1) EP0520200B1 (de)
JP (1) JPH05186432A (de)
AT (1) ATE163290T1 (de)
AU (1) AU653816B2 (de)
CA (1) CA2071793A1 (de)
DE (1) DE69224448T2 (de)
DK (1) DK0520200T3 (de)
ES (1) ES2113898T3 (de)
FI (1) FI922905L (de)
GR (1) GR3026467T3 (de)
IE (1) IE921650A1 (de)
NO (1) NO302119B1 (de)
NZ (1) NZ242951A (de)
ZA (1) ZA924117B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
DK154092D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
AU675484B2 (en) * 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
US5554630A (en) * 1993-03-24 1996-09-10 Neurosearch A/S Benzimidazole compounds
US5496826A (en) * 1994-09-02 1996-03-05 Bristol-Myers Squibb Company Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides
CN1089762C (zh) * 1995-04-21 2002-08-28 纽罗研究公司 苯并咪唑化合物及其用作gabaa受体复合物调节器的用途
DE69833858T2 (de) * 1997-07-08 2007-02-22 Ono Pharmaceutical Co. Ltd. Aminosäurederivate
WO1999032446A1 (en) 1997-12-22 1999-07-01 Ajinomoto Co., Inc. Novel dihydropyridine derivative
TWI245035B (en) 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
DE69924493T2 (de) * 1998-07-02 2005-09-15 Neurosearch A/S Kaliumkanal-blockierende mittel
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
WO2000004005A1 (en) 1998-07-14 2000-01-27 Ono Pharmaceutical Co., Ltd. Amino acid derivatives and drugs containing the same as the active ingredient
WO2000006559A1 (en) * 1998-07-30 2000-02-10 Warner-Lambert Company Reduced dipeptide analogues as calcium channel antagonists
WO2000078719A1 (en) 1999-06-23 2000-12-28 Ajinomoto Co., Inc. Dihydropyridine derivative
NZ519326A (en) * 2000-01-14 2005-02-25 Schering Ag 1,2-diarylbenzimidazoles for treating diseases that are associated with a microglia activation
US7115645B2 (en) 2000-01-14 2006-10-03 Schering Aktiengesellschaft 1,2 diarylbenzimidazoles and their pharmaceutical use
US7329679B2 (en) 2000-01-27 2008-02-12 Schering Aktiengesellschaft 1,2 Diarylbenzimidazoles and their pharmaceutical use
DE10135050A1 (de) * 2001-07-09 2003-02-06 Schering Ag 1-Ary1-2-N-, S- oder O-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
DE10207844A1 (de) * 2002-02-15 2003-09-04 Schering Ag 1-Phenyl-2-heteroaryl-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
KR100873400B1 (ko) * 2002-10-17 2008-12-11 한국과학기술연구원 Ｎ-타입 칼슘 채널의 활성을 억제함으로써 우울증을감소시키는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
JPH0772181B2 (ja) * 1989-06-26 1995-08-02 株式会社大塚製薬工場 ベンズイミダゾール誘導体
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments

Also Published As

Publication number Publication date
ATE163290T1 (de) 1998-03-15
FI922905A0 (fi) 1992-06-22
CA2071793A1 (en) 1992-12-25
DE69224448T2 (de) 1998-06-10
DE69224448D1 (de) 1998-03-26
EP0520200B1 (de) 1998-02-18
EP0520200A3 (en) 1993-05-12
NZ242951A (en) 1994-12-22
DK0520200T3 (da) 1998-09-23
FI922905A7 (fi) 1992-12-25
AU653816B2 (en) 1994-10-13
ZA924117B (en) 1993-03-31
NO922475D0 (no) 1992-06-23
EP0520200A2 (de) 1992-12-30
NO302119B1 (no) 1998-01-26
ES2113898T3 (es) 1998-05-16
JPH05186432A (ja) 1993-07-27
GR3026467T3 (en) 1998-06-30
NO922475L (no) 1992-12-28
IE921650A1 (en) 1992-12-30
AU1726792A (en) 1993-01-07

Similar Documents

Publication Publication Date Title
FI934573L (fi) Foerfarande och anordning foer ombesoerjning av svaroevervakning och en sjaelvstaendiga betaltelefon innehaollande densamma
FI921663A7 (fi) Foerfarande och anordning foer behandling av goedsel
FI922023L (fi) Ultrafiltreringsfoerfaranden foer aotervinning av polymerlatexer fraon bakvatten och anordning foer dessa
FI914848L (fi) Gaongjaernsanordning och anvaendning av densamma
FI88744B (fi) Foerfarande och anordning foer reglering av bergborrning
FI920396A7 (fi) Foerfarande foer reglering av en reaktiv sputteringsprocess och anordning foer utfoerande av foerfarandet
FI920716L (fi) Haellanordning foer foerpackningar innehaollande flytande aemnen och foerfarande foer framstaellning av en saodan anordning
FI925567L (fi) Foerfarande och anordning foer upplytning av styckegods
FI921866L (fi) Foerfarande foer framstaellning av laegre polyoler och blandningar daerav
FI921348L (fi) Komponenter och katalysatorer foer polymerisering av olefiner
FI912537L (fi) Fluffig organisk isoleringsmassa och foerfarande foer framstaellning och anvaendning av densamma
FI920424A7 (fi) Foerfarande foer anvaendning av metalliseringsanlaeggning och anordning foer utfoerande av foerfarandet
FI921839A7 (fi) Foerfarande och anordning foer bearbetning av tryckalster
FI921284L (fi) Framstaellnin av styva skum och komposition anvaendbar daeri
FI914551A7 (fi) Foerfarande och anordning foer boejning och haerdning av en glasskiva
FI921122L (fi) Kloning och uttryckning av acetylxylanesteraser av svampursprung
FI925741L (fi) Anordning och foerfarande foer kontinuerlig framstaellning av mineralullfibermattor
FI921575A7 (fi) Foerfarande och anordning foer tillslutning av behaollare
FI921861L (fi) Konverter och foerfarande foer inblaosning av ickejaernmetall uppifraon
FI912260A7 (fi) Foerfarande och anordning foer belaeggning av roerligt underlag
FI913985L (fi) Brandbegraensare och foerfarande foer laosning av tillslutningsorganet av brandbegraensaren
FI935789A7 (fi) Anlaeggning och foerfarande foer braenning av explosiva aemnen
FI922139L (fi) Foerfarande och anordning foer framstaellning av anhydrit-stygips
FI925187A7 (fi) Anordning foer oeppning och staengning av en sadelgolv-sjaelvtoemningsvagnstoemningslucka
FI914455A7 (fi) Foerfarande och anordning foer behandling av loesgods